Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lactobacillus casei is a probiotic bacterium that has been studied for its potential benefits in managing colitis, particularly ulcerative colitis and other forms of inflammatory bowel disease (IBD). The scientific rationale for its use centers on its ability to modulate the gut microbiota, enhance barrier function, and regulate immune responses. Some clinical trials and animal studies suggest that L. casei supplementation may help reduce inflammation and improve symptoms in colitis by inhibiting the production of pro-inflammatory cytokines, strengthening the intestinal mucosal barrier, and promoting the growth of beneficial bacteria. However, the overall quality and quantity of evidence is moderate at best. Systematic reviews and meta-analyses of probiotics in IBD often include L. casei among the strains studied, but results are mixed. Some studies show modest benefit in reducing relapse rates and improving clinical symptoms, especially when L. casei is used in combination with other probiotic strains (such as in the VSL#3 formulation). Others fail to demonstrate significant improvements over placebo. The heterogeneity in probiotic strains, doses, patient populations, and study designs makes it difficult to draw firm conclusions. In summary, while there is some scientific support for the use of Lactobacillus casei in colitis—particularly as part of multi-strain probiotic therapies—the evidence is not strong or consistent enough to warrant a higher rating. More large-scale, well-controlled clinical trials are needed to clarify its efficacy and optimal use.

More about Lactobacillus casei
More about Colitis

Other ingredients used for Colitis

Other health conditions supported by Lactobacillus casei

Products containing Lactobacillus casei

Nature's Sunshine Bifidophilus Flora Force
Nature's Sunshine Eleven Elevated (NutriBiome)
Nature's Sunshine Probiotic Eleven
Nature's Sunshine Sunshine Heroes Probiotic Power